Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Cognitive behavioral therapy (supportive counseling)Behavioral: Virtual Cardiac Rehabilitation
- Registration Number
- NCT05099679
- Lead Sponsor
- Stanford University
- Brief Summary
Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation services to address socioeconomic health disparities and improve wellbeing for black men with prostate cancer.
- Detailed Description
Subjects will see an oncology Associate Clinical Social Worker at Stanford's Cancer Center for a two hour psychosocial assessment. Subsequently participants will complete the psychosocial intake support session and elective additional counseling sessions (Part A) at the end of up to 8 counseling sessions (maximum sessions possible) or 20 weeks (+/- 4 weeks), whichever comes first. For participants who continue onto cardiac services (Part B), the participant will complete the cardiac rehabilitation exercise program within 12 weeks (+/- 2 weeks) of the first day of exercise start. The end of study will occur after the last cardiac rehabilitation exercise session (+ 2 weeks).
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 14
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Psychosocial intervention + Cardiac Rehab Services Cognitive behavioral therapy (supportive counseling) Cognitive Behavioral Therapy + Cardiac Rehab Psychosocial intervention + Cardiac Rehab Services Virtual Cardiac Rehabilitation Cognitive Behavioral Therapy + Cardiac Rehab
- Primary Outcome Measures
Name Time Method Proportion of Completers 12 weeks Proportion of screened eligible participants who complete the initial 2-hour psychosocial support session intake.
The pilot study is considered feasible if the primary endpoint is met in at least 50% of patients. We will evaluate the 95% CI of the feasibility rate.
- Secondary Outcome Measures
Name Time Method Difference of General Anxiety Disorder-7 (GAD-7) score 12 weeks Difference of Functional Assessment of Cancer Therapy-Prostate (FACT-P) score 12 weeks Difference in Patient Health Questionnaire-9 (PHQ-9) 12 weeks
Trial Locations
- Locations (1)
Stanford University
🇺🇸Palo Alto, California, United States